Triple arm, prospective, real-world study comparing the efficacy of FDC teneligliptin + dapagliflozin to FDC sitagliptin + dapagliflozin, and FDC linagliptin + empagliflozin in Indian type 2 diabetes mellitus patients using CGM device: the Amplify-TIR study.

ABSTRACT:

SUBMITTER: Erande S 

PROVIDER: S-EPMC12648778 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature